We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THCAU
5226
DELISTED
Tuscan Holdings Corp. II Unit
THCAU
$3K ﹤0.01%
281
– –
LBTYB
5227
DELISTED
Liberty Global plc Class B
LBTYB
$3K ﹤0.01%
96
+69
+256% +$2.16K
AMPG icon
5228
AmpliTech
AMPG
$155M
$2K ﹤0.01%
+451
New +$1.74K
ARTW icon
5229
Arts-Way Manufacturing Co
ARTW
$13.8M
$2K ﹤0.01%
444
-1,422
-76% -$5K
ATLO icon
5230
AMES National
ATLO
$282M
$2K ﹤0.01%
100
-660
-87% -$15.6K
ATNM icon
5231
Actinium Pharmaceuticals
ATNM
$24.9M
$2K ﹤0.01%
200
-3,608
-95% -$25.1K
AUID icon
5232
authID Inc
AUID
$9.26M
$2K ﹤0.01%
+19
New +$1.72K
AVAL icon
5233
Grupo Aval
AVAL
$6.38B
$2K ﹤0.01%
424
+265
+167% +$1.48K
BAOS icon
5234
Baosheng Media Group
BAOS
$972K
$2K ﹤0.01%
45
-152
-77% -$6.81K
BB icon
5235
BlackBerry
BB
$5.35B
$2K ﹤0.01%
243
+199
+452% +$2.09K
BFIN
5236
DELISTED
BankFinancial
BFIN
$2K ﹤0.01%
+145
New +$1.65K
KEEL
5237
Keel Infrastructure Corp
KEEL
$2.08B
$2K ﹤0.01%
+450
New +$2.21K
BPRN icon
5238
Princeton Bancorp
BPRN
$287M
$2K ﹤0.01%
56
-60
-52% -$1.79K
CETX icon
5239
Cemtrex
CETX
$5.01M
– –
0
– –
CHY
5240
Calamos Convertible and High Income Fund
CHY
$1.07B
$2K ﹤0.01%
+140
New +$2.26K
CMCM
5241
Cheetah Mobile
CMCM
$98.1M
$2K ﹤0.01%
308
+275
+833% +$2.7K
CNTA
5242
DELISTED
Centessa Pharmaceuticals
CNTA
$2K ﹤0.01%
119
-958
-89% -$19.8K
CREX icon
5243
Creative Realities
CREX
$39.2M
$2K ﹤0.01%
382
-308
-45% -$1.48K
CSIQ icon
5244
Canadian Solar
CSIQ
$1.07B
$2K ﹤0.01%
61
-237
-80% -$9.02K
CSPI icon
5245
CSP Inc
CSPI
$82.6M
$2K ﹤0.01%
366
+350
+2,188% +$1.69K
CYD icon
5246
China Yuchai International
CYD
$1.76B
$2K ﹤0.01%
122
-1,454
-92% -$21.1K
MYSE
5247
Myseum.AI Inc
MYSE
$12.5M
$2K ﹤0.01%
+13
New +$996
DBA icon
5248
Invesco DB Agriculture Fund
DBA
$1.24B
$2K ﹤0.01%
116
+1
+0.9% +$19
DGP icon
5249
DB Gold Double Long ETN due February 15, 2038
DGP
$253M
$2K ﹤0.01%
46
– –
ELA icon
5250
Envela
ELA
$413M
$2K ﹤0.01%
437
+100
+30% +$422
208 209
210
211 212

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.